1. South Australian Life Science Initiatives
Establishment of Bio Innovation SA
$35 million VC fund dedicated to early-stage life science companies
Thebarton Bioscience Precinct development
Whole-of-Government IP Policy enabling government-employed inventors to take equity
Adelaide Integrated Bioscience Laboratories (AIB Labs) network of core service providers

2. South Australian Capabilities
> 70 companies, 1000 employees, generating $175 million revenue*
Key institutes:
3 universities + 5 research hospitals
Institute for Medical & Veterinary Science (IMVS)
Australian Wine Research Institute (AWRI)
Australian Centre for Plant Functional Genomics (ACPFG)
Ian Wark Research Institute (IWRI) at UniSA
Key strengths in wine research, plant genomics, bioremediation, biomaterials, reproductive health, medical devices
*Data from 2004 survey of South Australia’s bioscience sector as conducted by Ernst & Young / Bio Innovation SA

3. South Australian Statistics
Several trial sites:
Royal Adelaide Hospital
Flinders Medical Centre
Queen Elizabeth Hospital
Women’s & Children’s Hospital
Repatriation General Hospital
Repromed
Focus areas include: cancer, viral diseases, reproductive conditions & paediatric health, cardiovascular & respiratory diseases, arthritis
Currently 44 clinical trials underway in Adelaide

4. Drug Development South Australia
Partnership between South Australia’s pre-clinical & clinical trial providers to provide access to services & promote capabilities
CMAX
vivoPharm Pty Ltd
Trident Clinical Research Pty Ltd
Centre for Pharmaceutical Research